“…Oral bioaccessibility tests are the most frequently investigated with the test methodology ranging from a static gastric compartment (Drexler and Brattin, 2007; EN, 2002; Stopford et al, 2003; U.S.EPA, 2007) to dynamic gastrointestinal models (Garcia et al, 2001; Juhasz et al, 2009; Rodriguez and Basta, 1999; Ruby et al, 1996; Velasco-Reynold et al, 2008). While multiple gastric methods persist, alloy dermal biofluid studies have generally used the EN 1811 reference method for allergenic responses via skin contact (Bocca et al, 2007; Flint, 1998; Julander et al, 2009; Midander et al, 2007b). However, far fewer studies have applied in vitro bioaccessibility tests to lung (Herting et al, 2008b; Midander et al, 2007b; Stopford et al, 2003; Thelohan and Demeringo, 1994; Twining et al, 2005; Vitarella et al, 2000) or internal implantation (Herting et al, 2008a; Stopford et al, 2003) biofluids to assess inhalation exposure to alloys.…”